Skip to main content
Figure 6 | BMC Genomics

Figure 6

From: The chromatin modification by SUMO-2/3 but not SUMO-1 prevents the epigenetic activation of key immune-related genes during Kaposi’s sarcoma associated herpesvirus reactivation

Figure 6

Overview of SUMO enrichment at IRF-1, IRF-2 and IRF-7 binding sites during viral reactivation. Percentage of SUMO-1 and SUMO-2/3 target gene numbers with SUMO enrichment at IRF-1 (A), IRF-2 (B) or IRF-7 (C) binding sites in promoter regions before and after K-Rta induction for KSHV reactivation; numbers indicate counts of overlapping and non-overlapping gene numbers.

Back to article page